↓ Skip to main content

In vitro treatment of 3 T3-L1 adipocytes with recombinant Calcium/calmodulin-dependent Protein Kinase IV (CaMKIV) limits ER stress and improves insulin sensitivity through inhibition of autophagy via…

Overview of attention for article published in BMC Endocrine Disorders, July 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
In vitro treatment of 3 T3-L1 adipocytes with recombinant Calcium/calmodulin-dependent Protein Kinase IV (CaMKIV) limits ER stress and improves insulin sensitivity through inhibition of autophagy via the mTOR/CREB signaling pathway
Published in
BMC Endocrine Disorders, July 2020
DOI 10.1186/s12902-020-00589-2
Pubmed ID
Authors

Jiali Liu, Ruihua Yang, Hao Meng, Ting Zhou, Qian He

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 16%
Student > Master 3 12%
Student > Bachelor 2 8%
Librarian 2 8%
Student > Doctoral Student 1 4%
Other 4 16%
Unknown 9 36%
Readers by discipline Count As %
Medicine and Dentistry 4 16%
Biochemistry, Genetics and Molecular Biology 3 12%
Social Sciences 3 12%
Agricultural and Biological Sciences 2 8%
Nursing and Health Professions 1 4%
Other 3 12%
Unknown 9 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2020.
All research outputs
#20,629,784
of 23,221,875 outputs
Outputs from BMC Endocrine Disorders
#641
of 784 outputs
Outputs of similar age
#339,993
of 397,211 outputs
Outputs of similar age from BMC Endocrine Disorders
#28
of 28 outputs
Altmetric has tracked 23,221,875 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 784 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 397,211 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.